FLEXISEQ

[ Surfactants and lipids for use in the manufacture of personal care products, chemical products for in vitro and in vivo use in research and development ]

Pharmaceutical preparations and substances for the treatment of pain and inflammation; [ veterinary and sanitary preparations and substances for the treatment of pain and inflammation; chemical preparations for pharmaceutical purposes, namely, for the treatment of pain and inflammation; diagnostic preparations and substances for medical purposes for in vivo use; pharmaceuticals for treating osteoarthritis, oncology, cardiovascular disease, respiratory disease, inflammation, infection, gastrointestinal diseases and central nervous system diseases; diagnostic preparation for medical and veterinary use; topical and parenteral preparations of vesicles, namely, liquids or gels for the treatment of pain and inflammation; chemical preparations for the treatment of pain and inflammation in the form of vesicles for medical and veterinary purposes; pharmaceutical preparations being chemical membranes and chemical aggregates for medical and veterinary purposes; pharmaceutical preparations of arachidonic acids for the treatment of pain and inflammation; dispersions and dry preparations of liposomal active substance carriers for use as a pharmaceutical, cosmetic substance carrier, in the nature of a liquid, gel, cream, lotion or lipid; cosmeceutical preparations in the nature of medicated cosmetics; local anesthetics; steroids; anti-inflammatory drugs; pharmaceuticals for the treatment of nail fungal infections; vaccines; immunotherapeutic vaccines; topical and parenteral lipids for use in the treatment of pain and inflammation; ] medicated creams, medicated dispersions, medicated lotions, medicated ointments, medicated gels [, medicated solutions, medicated sprays, medicated lacquers and pharmaceutical solutions which form a film on the skin for the treatment of pain and inflammation; surfactants for medical use in the treatment of or prevention of cancer, infectious disease, fungal diseases, disease caused by parasites, eye disease, diseases of the central and peripheral nervous systems, cardiovascular disease, diseases affecting the immune system, inflammatory diseases, single gene disorders, diseases of the mouth, teeth, skin, hair and ear, bone and blood diseases and reproductive system disorders, the treatment of inflammation, asthma, atopic eczema, dishydrotic hand eczema, plaque type psoriasis, seborrhoeic eczema, acne vulgaris, bronchospasm, atherothrombotic cardiovascular disorders, venous thrombotic disorders, pain, dysmenorrhea, hypercholesterolemia, hypertriglyceridemia, fatty acid metabolism, metal or other toxicity, Alzheimer's disease, gout, macular degeneration, age-related macular degeneration, fungal infection and disorders related to fatty acid deficiencies ]

[ Medical devices in the nature of a carrier with nanostructures which cross through the skin for the treatment of pain and inflammation associated with osteoarthritis; ] molecular filtering devices for medical use, namely, a liquid or gel as a drug delivery device which filters through the skin and has a physical therapeutic effect at the point of complaint; medical [, veterinary ] and surgical devices, namely, a medical device which acts as a drug delivery system in the nature of non-pharmaceutical nanostructures that migrate through the skin and have a physical therapeutic effect at the point of complaint [ ; inhalers for medical purposes sold empty; injection devices, namely, medical syringes and medical fluid injectors; medical instruments and devices for the administration of pain relief therapy and prophylaxis preparations and substances ]